Our Blood Institute

What it reported doing in 2024

These other program services are blood product derivatives. Derivatives are a product manufactured from a raw material byproduct of blood collection. Obi collects this material, which is unusable for blood transfusion, and distributes this byproduct to plasma manufacturers which, in turn, use it in the production of a biological drug. Revenue for this program is $363,515 with offsetting expenses totaling $302,514. The cell therapy program involves collections of stem cells and cord blood from patients, testing, and manufacturing the products for patient use. Revenue for this program is $473,254 with offsetting expenses totaling $831,738. Obi manages the life-saving blood donations of more than 200,000 people in the region each year. These units of blood are eventually delivered to patients across the region, but not before undergoing an immense amount of fda-regulated processing and testing for donor and blood recipient safety. Volunteer blood donors give what can't be created and provided by any other means. Obi recruits donors and provides skilled medical staff, technology, and facilities to collect blood from donors. Lab professionals under the medical supervision of physicians prepare the blood for transfusion and administer multiple safety tests. All must be done with utmost urgency and around the clock since blood has a very limited time for use. Obi administers five layers of safety procedures - blood donor eligibility standards, individual screening, laboratory testing, confidential exclusion of donations and donor record checks. Extensive compliance and technical tenure are required to get blood from a donor to a patient. Blood centers also work closely with government agencies and other entities on quality control and tracking. An entire team manages the supply logistics with every medical facility served so that they have the right blood at the right time for patients. This can fluctuate greatly, even within a few hours. Couriers travel more than six million miles each year to transport donated blood to central labs and hospitals with accuracy and efficiency, leaving no need unmet, regardless of the situation or travel conditions. Hospitals and patients are not charged for the donated blood itself. Expenses are recovered through a service fee for employee wages, fuel, vehicles, advanced testing equipment and blood processing as summarized above. Obi's fees and quality have made it the chosen, sole supplier for more than 90 percent of Oklahoma's blood supply, as well as more than 40 Arkansas hospitals, eight hospitals in the texoma region and most hospitals in the Texas high plains region. It requires 24/7, 365 days-a-year staffing and operations, much like area hospitals. In addition to these services, obi plays a critical role in trauma care. Type o whole blood, containing red cells, platelets, and plasma, is crucial in trauma because it can be safely used for patients of any blood type. The importance of this initiative is underscored by its success in Oklahoma city, where whole blood was introduced to ems in 2023. From its launch in february 2023 to june 2024, okc ems providers have administered whole blood to 58 patients on-site before hospital arrival, with 48 surviving to emergency department admission and 34 eventually being discharged.

Financial Efficiency

• Mission deployment rate: 84.2%; rating input score 84
• Program expense ratio: 85.2%; rating input score 85
• Fundraising efficiency: Limited

Transparency & Controls

• Consistency checks: 92.9%; rating input score 93; 17th percentile among comparable filings
• Pay-setting controls: 3 of 6 controls in place; rating input score 50
  • Compensation committee: Missing
  • Independent consultant: Missing
  • Other Form 990s reviewed: Pass
  • Written employment contract: Missing
  • Compensation survey or study: Pass
  • Board or committee approval: Pass
• Foreign activity oversight: Limited
• Grant itemization coverage: 69.2%; rating input score 69; 14th percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Yes; rating input score 100

Accountability

• Independent voting board: 75%; rating input score 75; 24th percentile among comparable filings
• Governance controls: 9 of 9 controls in place; rating input score 100
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Pass
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: 4%; rating input score 52; 52nd percentile among comparable filings
• Total-asset coverage ratio: 0.8; rating input score 32; 32nd percentile among comparable filings
• Liabilities to assets ratio: 0.23; rating input score 65; 65th percentile among comparable filings
• Officer compensation ratio: 3.9%; rating input score 27; 27th percentile among comparable filings

Growth

• Program expense growth: 4.4% per year; rating input score 100; 34th percentile among comparable filings
• Revenue growth: 5.2% per year; rating input score 100; 45th percentile among comparable filings
• Asset growth: 7.1% per year; rating input score 100; 52nd percentile among comparable filings